Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
Faul
P
P
Urologische Abteilung, Stadtkrankenhaus Memmingen, BRD.
D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D009919:Orchiectomy; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate
D000726:Androgen Antagonists; D000970:Antineoplastic Agents